4093-34-9

Basic information

• Product Name: Methyl 4-acetamido-5-bromo-2-methoxybenzoate
• Synonyms: 4-ACETYLAMINO-5-BROMO-2-METHOXY-BENZOIC ACID METHYL ESTER;methyl 4-(acetylamino)-5-bromo-o-anisate;Methyl-2-methoxy-4-acetylamino-5-bromobenzoate;4-Acetamido-5-bromo-2-methoxybenzoic acid methyl ester;Methyl 4-acetamido-5-bromo-2-methoxybenzoate
• CAS NO: 4093-34-9
• Molecular Formula: C₁₁H₁₂BrNO₄
• Molecular Weight: 302.12
• EINECS: 223-841-7
• Mol File: 4093-34-9.mol
• Article Data: 9

Chemical Properties

• Melting Point: 174 °C
• Boiling Point: 449.7 °C at 760 mmHg
• Flash Point: 225.8 °C
• Appearance: /
• Density: 1.506 g/cm³
• Vapor Pressure: 2.81E-08mmHg at 25°C
• Refractive Index: 1.579
• Storage Temp.: 2-8°C
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 13.16±0.70(Predicted)
• Water Solubility: 391.5mg/L at 25℃
• CAS DataBase Reference: Methyl 4-acetamido-5-bromo-2-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-acetamido-5-bromo-2-methoxybenzoate(4093-34-9)
• EPA Substance Registry System: Methyl 4-acetamido-5-bromo-2-methoxybenzoate(4093-34-9)

Safety Data

• Hazardous Substances Data: 4093-34-9(Hazardous Substances Data)

Usage

Uses

Methyl 4-Acetamido-5-bromo-2-methoxybenzoate is an impurity of bromopride (B686645), which is an antimetic.

Flammability and Explosibility

Notclassified

InChI:InChI=1/C11H12BrNO4/c1-6(14)13-9-5-10(16-2)7(4-8(9)12)11(15)17-3/h4-5H,1-3H3,(H,13,14)

Upstream product

• 65-49-6 4-Aminosalicylic acid 
• 4093-29-2 methyl 4-(acetylamino)-o-anisate 
• 4093-28-1 methyl 4-acetamido-2-hydroxybenzoate 
• 4136-97-4 methyl 4-aminosalicylate 
• 39106-79-1 methyl 2-methoxy-4-nitrobenzoate 
• 27492-84-8 Methyl 4-amino-2-methoxybenzoate 

Downstream Products

• 35290-97-2 4-amino 5-bromo 2-methoxy benzoic acid 

Relevant articles and documents

Preparation method for pharmacopoeia impurity of amisulpride

The invention reports a preparation method for a pharmacopoeia impurity of amisulpride, and particularly relates to a preparation method for the pharmacopoeia impurity D of amisulpride. The method is simple and easy to operate, mild in condition, high in yield, low in energy consumption and pollution and suitable for laboratory-level standard substance preparation.

QUINAZOLINE-BASED KINASE INHIBITORS

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.

ARYL AMIDE KINASE INHIBITORS

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.